The Drug Delivery Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the drug delivery partnering deals and agreements entered into by the worlds leading healthcare companies.
The report provides a detailed understanding and analysis of how and why companies enter drug delivery partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors drug delivery technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.
Understanding the flexibility of a prospective partnerís negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered Ė contract documents provide this insight where press releases do not.
This report contains over 2,000 links to online copies of actual drug delivery deals and contract documents as submitted to the
The initial chapters of this report provide an orientation of drug delivery deal making and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of the trends in drug delivery deal making since 2007, including details of average headline, upfront, milestone and royalty terms.
Chapter 3 provides a review of the leading drug delivery deals since 2007. Deals are listed by headline value, signed by bigpharma, most active bigpharma, and most active of all biopharma companies. Where the deal has an agreement contract published at the
Chapter 4 provides a comprehensive listing of the top 50 bigpharma companies with a brief summary followed by a comprehensive listing of drug delivery deals as well as contract documents available in the public domain. Where available, each deal title links via
Chapter 5 provides a comprehensive and detailed review of drug delivery partnering deals signed and announced since 2007, where a contract document is available in the public domain. The chapter is organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and specific therapy focus. Each deal title links via
Chapter 6 provides a comprehensive and detailed review of drug delivery partnering deals organized by specific drug delivery technology type. Each deal title links via
Most Popular Stories
- Bipartisan Budget Deal Gets Key Support in House
- Bitcoin Clones Lurch Onto Financial Scene
- Clinton to Keynote Annual Simmons Leadership Conference
- Futures Fall, Holiday Spending and Unemployment Up
- Budget Deal Will Cut 220,000 Californians Out of Jobless Benefits
- Senate Not So Keen on Budget Deal
- Oil Nears $98 a Barrel
- PhD Project Grooms Business Profs
- Selena Gomez, Shakira Among Top Hispanic Searches
- GM to Stop Making Autos in Australia